Search for: "State v. Bristol-Myers Squibb Company " Results 81 - 100 of 159
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
8 May 2020, 3:21 pm
Although Revolution lists on its website several companies where its products can be purchased, none of the listed companies are located in Illinois. [read post]
11 Mar 2019, 10:15 am by Scott Sternberg
Bristol-Myers Squibb Co., 919 F.3d 699 (2d Cir. 2019) followed suit and unanimously affirmed snap removal as a procedural vehicle to remove to federal court. [read post]
18 Sep 2023, 9:01 pm by Rodger Citron and Laura Dooley
 Justice Sotomayor’s vote here was consistent with her dissent in a 2017 case involving suits filed by individuals from different states against Bristol-Myers Squibb (“BMS”) in California state court. [read post]
19 Jun 2014, 8:11 am
TAP Pharmaceuticals (Bristol Myers Squibb Appeal), No. 85 MAP 2011, slip op. [read post]
22 Aug 2012, 7:51 am by arester
Bristol-Myers Squibb Co., resulting in $515 million settlement arising from unlawful conduct including off-label promotion to induce government purchases of the antipsychotic drug Abilify; and United States ex rel. [read post]
9 Oct 2020, 9:57 am by Howard M. Wasserman
The case is controlled by the court’s 2017 decision in Bristol-Myers Squibb v. [read post]
26 Apr 2024, 12:05 pm by admin
Earlier in the winter of 1996, George Gore (Al’s cousin) tried a silicone breast implant case for Bristol Myers Squibb in Oregon state court. [read post]
21 Jun 2010, 9:57 am
They ask as follows: "(i) Are Article 7(2) of [the repealed and re-enacted but regularly cited] Council Directive 89/104 ... to approximate the laws of the Member States relating to trade marks and the associated case-law, in particular the judgments of the Court of Justice in Cases 102/77 Hoffmann-La Roche v Centrafarm and 1/81 Pfizer v Eurim-Pharm and Joined Cases C-427/93, C-429/93 and C-436/93 Bristol-Myers Squibb and Others v… [read post]
31 Oct 2008, 11:53 am
You can separately subscribe to the Pharma & Biotech edition of the IP Think Tank Global Week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Oxytrol (Oxybutynin) - US: Watson files patent infringement lawsuit against Barr over application to market generic Oxytrol; Barr challenges Oxytrol patent… [read post]
12 Jun 2018, 6:56 am by Joy Waltemath
The agency’s argument that the regulation leaves the decision up to the employer was unavailing, the court explained, under the competitor standing doctrine and had already been rejected in earlier cases, such as Bristol-Myers Squibb Co. v. [read post]
20 Mar 2023, 7:52 am by Rebecca Tushnet
Bristol-Myers Squibb Co., 2023 WL 2519857, SCAP-21-0000363, --- P.3d ---- (Hawai’i Mar. 15, 2023) The state sued two pharmaceutical companies for violating Hawai‘i’s Unfair or Deceptive Acts or Practices law (UDAP) by misleading the public about the safety and efficacy of their antiplatelet drug, Plavix. [read post]
20 Jun 2017, 4:29 am by Edith Roberts
And in Bristol-Myers Squibb Co. v. [read post]